RYTM
Rhythm Pharmaceuticals, Inc.
$119.04+2.43 (+2.08%)Close Nov 18, 2026
Loading the growth chart…
Growth of $10,000
Oct 9, 2017 – Nov 18, 2026, Dividends reinvested
- Final balance
- $48,449
- CAGR
- +18.91%
- Max drawdown
- −92.10%
Trailing returns (%)
RYTM's average annual return was 59.75% over the last 5 years, through Nov 18, 2026. $10,000 in RYTM on Nov 18, 2021 grew to $104,056 by Nov 18, 2026, with dividends reinvested.
Total
- 1M
- +38.15%
- 3M
- +3.29%
- 6M
- +37.08%
- YTD
- +11.21%
- 1Y
- +18.44%
Per year
- 3Y
- +52.12%
- 5Y
- +59.75%
- Since 2017
- +18.91%
Annual returns
2017 from Oct 9 · 2026 through Nov 18
RYTM returns by year
| Year | Return |
|---|---|
| 2026 through Nov 18 | +11.21% |
| 2025 | +91.21% |
| 2024 | +21.78% |
| 2023 | +57.86% |
| 2022 | +191.78% |
| 2021 | −66.43% |
| 2020 | +29.49% |
| 2019 | −14.58% |
| 2018 | −7.50% |
| 2017 from Oct 9 | +18.27% |
Metrics
Since 2017| Volatility | 70.26% |
|---|---|
| Sharpe ratio | 0.59 |
| Sortino ratio | 0.95 |
| Calmar ratio | 0.21 |
| Longest drawdown | 2.9 years |
Worst drawdowns
Since 2017| Decline | Peak | Bottom | Recovered | Length |
|---|---|---|---|---|
| −92.1% | Jan 2021 | May 2022 | Dec 2023 | 2.9 years |
| −63.3% | Jul 2018 | Mar 2020 | Jan 2021 | 2.5 years |
| −47.2% | Jan 2018 | Apr 2018 | Jun 2018 | 4 months |
| −35.5% | Dec 2025 | Mar 2026 | Nov 2026 | 11 months |
| −32.5% | Feb 2024 | May 2024 | Jul 2024 | 5 months |